← Leaderboards
James Leif Smith
Mississippi State University
$4,201,255
Attributed
$4,201,255
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2009–24$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$4,201,255 · 6
By mechanism
R42$3,179,375 · 2
R41$987,556 · 3
R15$34,324 · 1
Top collaborators
No co-investigators on record.
Most similar at Mississippi State University
Same institution · by research overlap
- Frank William Austin$210,506
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionDoseToxic EffectInvestigational New Drug ApplicationNovel TherapeuticsMycosesPredispositionPreclinical DevelopmentFluconazoleBurkholderiaProductionCellsPeptidesCaspofunginYeastsLiquid SubstanceFungusNatural ProductsApoptosisIn VitroAnalogInvestigational DrugsPeriodicityIndustrial Fungicide
Grant awards (9)
Preclinical Development of Occidiofungin for Treatment of Oral and Dermal Candidiasis$300,000
R42 · FY2024 · AI · contact PI
Preclinical Development of OCF001 for Treatment of Yeast Infections$930,515
R42 · FY2021 · AI · contact PI
Preclinical Development of OCF001 for Treatment of Yeast Infections$965,515
R42 · FY2020 · AI · contact PI
A Novel Therapeutic Agent for the Treatment of Gram-positive Infections$233,066
R41 · FY2020 · AI · contact PI
Preclinical Development of OCF001 for Treatment of Yeast Infections$983,345
R42 · FY2019 · AI · contact PI
Optimization of the Production and Isolation of the Novel Antifungal Occidiofungin$234,170
R41 · FY2017 · AI · contact PI
Lead Compound Discovery from Engineered Analogs of Occidiofungin$224,939
R41 · FY2017 · AI · contact PI
Optimization of the Production and Isolation of the Novel Antifungal Occidiofungin$295,381
R41 · FY2016 · AI · contact PI
Functional Characterization of the Site Specific Residues in Mutacin 1140$34,324
R15 · FY2009 · AI · contact PI